Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · IEX Real-Time Price · USD
5.46
+0.02 (0.37%)
At close: Apr 18, 2024, 4:00 PM
5.40
-0.06 (-1.10%)
After-hours: Apr 18, 2024, 7:57 PM EDT
Candel Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Candel Therapeutics stock have an average target of 7.00, with a low estimate of 3.00 and a high estimate of 11. The average target predicts an increase of 28.21% from the current stock price of 5.46.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2023.
Analyst Ratings
The average analyst rating for CADL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +101.47% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +101.47% | May 22, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $9 → $3 | Buy | Maintains | $9 → $3 | -45.05% | May 15, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +28.21% | Mar 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +46.52% | Dec 7, 2022 |
Financial Forecast
Revenue This Year
110.50K
Revenue Next Year
n/a
from 110.50K
EPS This Year
-0.81
from -1.31
EPS Next Year
-0.93
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | 25.5M |
| Avg | n/a | 24.8M |
| Low | n/a | 23.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.96 | -0.47 |
| Avg | -0.93 | -0.45 |
| Low | -0.89 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.